This website is intended for healthcare professionals only.

Newsletter          
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

Clinical

Dupilumab approved by EC for adolescents with moderate-to-severe atopic dermatitis
Dupilumab approved by EC for adolescents with moderate-to-severe atopic dermatitis
Researchers make immunotherapy work for treatment-resistant lymphoma
Researchers make immunotherapy work for treatment-resistant lymphoma
Shrinking brain tumours and opening the door for targeted cancer therapies
Shrinking brain tumours and opening the door for targeted cancer therapies
Expert view: Why are allergies on the rise?
Expert view: Why are allergies on the rise?
Offer daily aspirin to those with inherited genetic condition to reduce risk of cancer
Offer daily aspirin to those with inherited genetic condition to reduce risk of cancer
Immune cell subtype in mice that drives allergic reactions discovered
Immune cell subtype in mice that drives allergic reactions discovered
Scottish capital is global hotspot for inflammatory bowel disease rates
Scottish capital is global hotspot for inflammatory bowel disease rates
75% of asthma sufferers unable to work to their full potential
75% of asthma sufferers unable to work to their full potential
Positive opinion for cannabidiol oral solution in two rare childhood-onset epilepsies
Positive opinion for cannabidiol oral solution in two rare childhood-onset epilepsies
Antibiotics can inhibit skin lymphoma
Antibiotics can inhibit skin lymphoma
Lonsurf receives positive CHMP opinion
Lonsurf receives positive CHMP opinion
Stelara receives positive opinion for moderately to severely active ulcerative colitis
Stelara receives positive opinion for moderately to severely active ulcerative colitis


Popular articles

Aggressive end-of-life care more common in nursing home compared to community residents
Higher plasma caffeine levels linked to reduced body fat and type 2 diabetes risk according to genetic study
Shorter tuberculosis treatment strategy non-inferior to standard regimen
Prostate cancer mortality no different in trial of three treatment interventions
High-sensitivity CRP superior to LDL cholesterol for CV event and mortality risk prediction




 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora